Miletich JP - Search Results

1

Factor V Leiden and risks of recurrent idiopathic venous thromboembolism.

Ridker PM, Miletich JP, Stampfer MJ, Goldhaber SZ, Lindpaintner K, Hennekens CH. Ridker PM, et al. Among authors: miletich jp. Circulation. 1995 Nov 15;92(10):2800-2. doi: 10.1161/01.cir.92.10.2800. Circulation. 1995. PMID: 7586244

2

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.

Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Ridker PM, et al. Among authors: miletich jp. N Engl J Med. 1995 Apr 6;332(14):912-7. doi: 10.1056/NEJM199504063321403. N Engl J Med. 1995. PMID: 7877648 Free article.

3

Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.

Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Miletich JP. Ridker PM, et al. Among authors: miletich jp. Circulation. 1997 Jan 7;95(1):59-62. doi: 10.1161/01.cir.95.1.59. Circulation. 1997. PMID: 8994417

4

Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation.

Ridker PM, Glynn RJ, Miletich JP, Goldhaber SZ, Stampfer MJ, Hennekens CH. Ridker PM, et al. Among authors: miletich jp. Ann Intern Med. 1997 Apr 1;126(7):528-31. doi: 10.7326/0003-4819-126-7-199704010-00005. Ann Intern Med. 1997. PMID: 9092318

5

Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism.

Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ. Ridker PM, et al. Among authors: miletich jp. Circulation. 1997 Apr 1;95(7):1777-82. doi: 10.1161/01.cir.95.7.1777. Circulation. 1997. PMID: 9107163

6

Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening.

Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ridker PM, et al. Among authors: miletich jp. JAMA. 1997 Apr 23-30;277(16):1305-7. JAMA. 1997. PMID: 9109469

7

Factor V Leiden mutation as a risk factor for recurrent pregnancy loss.

Ridker PM, Miletich JP, Buring JE, Ariyo AA, Price DT, Manson JE, Hill JA. Ridker PM, et al. Among authors: miletich jp. Ann Intern Med. 1998 Jun 15;128(12 Pt 1):1000-3. doi: 10.7326/0003-4819-128-12_part_1-199806150-00007. Ann Intern Med. 1998. PMID: 9625662

8

G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men.

Ridker PM, Hennekens CH, Miletich JP. Ridker PM, et al. Among authors: miletich jp. Circulation. 1999 Mar 2;99(8):999-1004. doi: 10.1161/01.cir.99.8.999. Circulation. 1999. PMID: 10051291

9

G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism.

Miles JS, Miletich JP, Goldhaber SZ, Hennekens CH, Ridker PM. Miles JS, et al. Among authors: miletich jp. J Am Coll Cardiol. 2001 Jan;37(1):215-8. doi: 10.1016/s0735-1097(00)01080-9. J Am Coll Cardiol. 2001. PMID: 11153741 Free article.

10

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.

Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ; PREVENT Investigators. Ridker PM, et al. Among authors: miletich jp. N Engl J Med. 2003 Apr 10;348(15):1425-34. doi: 10.1056/NEJMoa035029. Epub 2003 Feb 24. N Engl J Med. 2003. PMID: 12601075 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters